Financhill
Back

Altimmune 10K Form

Sell
43

ALT
Altimmune

Last Price:
6.79
Seasonality Move:
13.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALT News And Ratings

See the #1 stock for the next 7 days that we like better than ALT

ALT Financial Statistics

Sales & Book Value

Annual Sales: $426K
Cash Flow: $-18.11M
Price / Cash Flow: 0
Annual Sales: $2.15
Price / Book: 3.16

Profitability

EPS (TTM): -1.64000
Net Income (TTM): $-101.35M
Gross Margin: $17.91M
Return on Equity: -60.49%
Return on Assets: -54.95%

Altimmune Earnings Forecast

Key Altimmune Financial Ratios

  • The Gross Profit Margin over the past 9 years for ALT is 100.00%.
  • The Selling, General & Administrative Expenses for ALT have been equal to 4,257.51% of Gross Profit Margin.
  • The Research & Development expenses have been 15,445.77% of Revenue.
  • The Interest Expense is -0.04% of Operating Income.
  • The Net Earning history of ALT is -20,762.21% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 11 years.

Altimmune Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALT
CUSIP: 02155H
Website: altimmune.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 11.3
Quick Ratio: 11.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ALT Technical Analysis vs Fundamental Analysis

Sell
43
Altimmune (ALT) is a Sell

Is Altimmune a Buy or a Sell?

  • Altimmune stock is rated a Sell
    The current Altimmune [ALT] share price is $6.79. The Score for ALT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.